Seguir
Gareth Jones
Gareth Jones
E-mail confirmado em petermac.org
Título
Citado por
Citado por
Ano
Amyloid imaging results from the Australian Imaging, Biomarkers and Lifestyle (AIBL) study of aging
CC Rowe, KA Ellis, M Rimajova, P Bourgeat, KE Pike, G Jones, J Fripp, ...
Neurobiology of aging 31 (8), 1275-1283, 2010
11292010
Longitudinal assessment of Aβ and cognition in aging and Alzheimer disease
VL Villemagne, KE Pike, G Chételat, KA Ellis, RS Mulligan, P Bourgeat, ...
Annals of neurology 69 (1), 181-192, 2011
10192011
Imaging of amyloid β in Alzheimer's disease with 18F-BAY94-9172, a novel PET tracer: proof of mechanism
CC Rowe, U Ackerman, W Browne, R Mulligan, KL Pike, G O'Keefe, ...
The Lancet Neurology 7 (2), 129-135, 2008
7862008
Relationship between atrophy and β‐amyloid deposition in Alzheimer disease
G Chételat, VL Villemagne, P Bourgeat, KE Pike, G Jones, D Ames, ...
Annals of neurology 67 (3), 317-324, 2010
4532010
Amyloid imaging with 18F-florbetaben in Alzheimer disease and other dementias
VL Villemagne, K Ong, RS Mulligan, G Holl, S Pejoska, G Jones, ...
Journal of Nuclear Medicine 52 (8), 1210-1217, 2011
4072011
Aβ deposits in older non-demented individuals with cognitive decline are indicative of preclinical Alzheimer's disease
VL Villemagne, KE Pike, D Darby, P Maruff, G Savage, S Ng, ...
Neuropsychologia 46 (6), 1688-1697, 2008
3102008
Regional dynamics of amyloid-β deposition in healthy elderly, mild cognitive impairment and Alzheimer’s disease: a voxelwise PiB–PET longitudinal study
N Villain, G Chételat, B Grassiot, P Bourgeat, G Jones, KA Ellis, D Ames, ...
Brain 135 (7), 2126-2139, 2012
2982012
Visual assessment versus quantitative assessment of 11C-PIB PET and 18F-FDG PET for detection of Alzheimer's disease
S Ng, VL Villemagne, S Berlangieri, ST Lee, M Cherk, SJ Gong, ...
Journal of nuclear medicine 48 (4), 547-552, 2007
2912007
The 18F-FDG PET cingulate island sign and comparison to 123I-β-CIT SPECT for diagnosis of dementia with Lewy bodies
SM Lim, A Katsifis, VL Villemagne, R Best, G Jones, M Saling, J Bradshaw, ...
Journal of Nuclear Medicine 50 (10), 1638-1645, 2009
2802009
Predicting Alzheimer disease with β‐amyloid imaging: results from the Australian imaging, biomarkers, and lifestyle study of ageing
CC Rowe, P Bourgeat, KA Ellis, B Brown, YY Lim, R Mulligan, G Jones, ...
Annals of neurology 74 (6), 905-913, 2013
2512013
Comparison of 11C-PiB and 18F-florbetaben for Aβ imaging in ageing and Alzheimer’s disease
VL Villemagne, RS Mulligan, S Pejoska, K Ong, G Jones, G O’Keefe, ...
European journal of nuclear medicine and molecular imaging 39, 983-989, 2012
2082012
High striatal amyloid β-peptide deposition across different autosomal Alzheimer disease mutation types
VL Villemagne, S Ataka, T Mizuno, WS Brooks, Y Wada, M Kondo, ...
Archives of neurology 66 (12), 1537-1544, 2009
2072009
Accelerated cortical atrophy in cognitively normal elderly with high β-amyloid deposition
G Chételat, VL Villemagne, N Villain, G Jones, KA Ellis, D Ames, ...
Neurology 78 (7), 477-484, 2012
2052012
Head-to-head comparison of 11C-PiB and 18F-AZD4694 (NAV4694) for β-amyloid imaging in aging and dementia
CC Rowe, S Pejoska, RS Mulligan, G Jones, JG Chan, S Svensson, ...
Journal of Nuclear Medicine 54 (6), 880-886, 2013
1972013
Epilepsyecosystem. org: crowd-sourcing reproducible seizure prediction with long-term human intracranial EEG
L Kuhlmann, P Karoly, DR Freestone, BH Brinkmann, A Temko, ...
Brain 141 (9), 2619-2630, 2018
1952018
Larger temporal volume in elderly with high versus low beta-amyloid deposition
G Chetelat, VL Villemagne, KE Pike, JC Baron, P Bourgeat, G Jones, ...
Brain 133 (11), 3349-3358, 2010
1692010
In vivo measurement of vesicular monoamine transporter type 2 density in Parkinson disease with 18F-AV-133
N Okamura, VL Villemagne, J Drago, S Pejoska, RK Dhamija, ...
Journal of Nuclear Medicine 51 (2), 223-228, 2010
1522010
A blood-based predictor for neocortical Aβ burden in Alzheimer’s disease: results from the AIBL study
SC Burnham, NG Faux, W Wilson, SM Laws, D Ames, J Bedo, AI Bush, ...
Molecular psychiatry 19 (4), 519-526, 2014
1292014
Independent contribution of temporal β-amyloid deposition to memory decline in the pre-dementia phase of Alzheimer’s disease
G Chetelat, VL Villemagne, KE Pike, KA Ellis, P Bourgeat, G Jones, ...
Brain 134 (3), 798-807, 2011
1222011
Stronger effect of amyloid load than APOE genotype on cognitive decline in healthy older adults
YY Lim, KA Ellis, RH Pietrzak, D Ames, D Darby, K Harrington, RN Martins, ...
Neurology 79 (16), 1645-1652, 2012
1202012
O sistema não pode executar a operação agora. Tente novamente mais tarde.
Artigos 1–20